Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung CancerJustin F. Gainor, Ted W. Johnson, Ramin Sakhtemani et al.|Clinical Cancer Research|2021Cited by 137
Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patientsHua‐Jun Wu, Franziska Michor, Daniel Temko et al.|Cell Genomics|2022Cited by 51